JARVIK HEART, Inc., a privately-held company that develops and manufactures cardiac assist devices, announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval to the Shonin (or pre-market approval)...
The United States may be losing ground as the leader in biomedical research and within the next...
Apollo Hospitals and Medtronic Announce a Collaboration to Bring an Affordable, Portable Hemodialysis System to IndiaOctober 9, 2013 5:06 am | by The Associated Press | News | Comments
Apollo Hospitals Enterprise Ltd., one of the leading healthcare providers in Asia, and Medtronic...
A new booklet from Theorem Clinical Research is now available to help researchers at medical...
Micell Technologies, Inc. has entered into an agreement with Hefei Life Science Technology Park Investment and Development Co., Ltd. (Hefei Life Science), for the clinical development, marketing and distribution of the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent...
Keystone Heart, a leader in the development of cerebral protection devices for interventional cardiology and cardiac surgery procedures, announced today that its TriGuardT Cerebral Protection Device has received CE Marking, enabling the company to commercially market the TriGuard in Europe and other territories.
It's no secret that the medical device sector sees emerging markets such as China and Brazil as their best opportunity for top-line growth over the next decade. But to ensure their expansion into emerging markets, device companies will have to conduct more clinical activities in these high-growth countries so they can market their new products there.
A slow heart rhythm puts patients at risk of early death, but a cardiac implant may help reset those odds, according to a Dutch study presented this week at the European Society of Cardiology Congress in Amsterdam. A study of pacemakers in 23 Dutch hospitals found that devices implanted to treat slow heart rhythm helped restore normal life expectancy.
Medtech titan Medtronic opened the doors on a new Center of Excellence in Singapore, where new business models will be designed, tested and scaled for Asian markets. Based in Medtronic's existing Singapore facility, the new center will also develop commercial models that may eventually extend to various markets around the globe after passing muster in a single country.
The European market for orthopedic biomaterials saw a decline between 2010 and 2012 due to a period of economic uncertainty and severe budgetary restrictions. However, this rate of decline has been diminishing, a promising sign for future growth.
Medtronic Announces Formation of Hospital Solutions Business Aimed at Driving Efficiencies and Cost SavingsSeptember 2, 2013 12:06 pm | by The Associated Press | News | Comments
Medtronic, Inc. (NYSE: MDT) today announced the formation of Medtronic Hospital Solutions, a new business focused on developing novel partnerships with hospitals to provide services directly related to hospital operational efficiency. The new business will focus initially on offering services in Europe...
Five of the ten largest medical device markets in the world are in Western Europe; Germany, France, the UK, Italy and Spain. Like all other sectors, the medical device markets will be impacted by the current eurozone crisis in the short term. This is a danger for domestic manufacturing industries, especially in Germany, which rely on demand for exports of their products.
Massachusetts medical device maker Covidien is opening the doors on a new Center of Innovation in South Korea, a country that the company calls "a key market in our global strategy." Covidien plans to spend $21 million over the course of 3 years to support the center...
The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many SegmentsAugust 22, 2013 8:00 am | by PR Newswire | News | Comments
According to Millennium Research Group, the global authority on medical technology market intelligence, efforts to streamline the regulatory approval process in Japan have resulted in the recent entry of numerous devices in the Japanese peripheral vascular (PV) device market, and more products, such as drug-coated balloons and infrapopliteal stents, are expected to enter in the next few years.
Frost & Sullivan: Technology as a Competitive Differentiator Fuels Adoption of Electronic Medical Records in Brazilian HospitalsAugust 8, 2013 3:59 pm | by PR Newswire | News | Comments
Intensifying competition among private hospitals in Brazil has compelled them to use advanced clinical systems as a market differentiator, thereby driving the uptake of electronic medical records (EMR). The need to reduce expenses in both public and private hospitals has further fuelled EMR installations in the country.
Healthcare giant Johnson and Johnson says it is pleased to put a legal dispute behind it after a Chinese court ordered it to pay compensation to a former distributor under an anti-monopoly law. Thursday's ruling said Johnson & Johnson was guilty of "vertical monopoly" for setting minimum prices its distributors charged for surgical sutures.
Johnson & Johnson (NYSE:JNJ) won the dubious distinction of being the 1st Fortune 500 company to be fined for price fixing in China, according to a newspaper there. The healthcare giant was fined 530,000 yuan (about $86,456) by the Shanghai High People's Court yesterday to compensate a former Chinese distributor, Rainbow Medical, China Daily reported.
When it comes to business and manufacturing, I have to admit, I’m not always the “Rah! Rah! USA!” guy. As a consumer, I believe in getting the best product for my dollar, regardless of where it is made. My mother used to continue to buy U.S. cars because she believed in “buying American” even though each and every car she got would give her some sort of mechanical problem for a significant amount of the time that she owned it.
A simple vinegar test slashed cervical cancer death rates by one-third in a remarkable study of 150,000 women in the slums of India, where the disease is the top cancer killer of women. Doctors reported the results Sunday at a cancer conference in Chicago.
ZURICH & DUESSELDORF, Germany--(BUSINESS WIRE)--May 16, 2013--The fifth annual EuroMedtech™ partnering conference concluded last week in Duesseldorf, Germany. EuroMedtech is Europe’s leading medical technology partnering conference where participants engage with potential partners around in-...
It’s no secret that getting a medical device to market can be a lengthy, frustrating process. Facing the new medical device excise tax and lack of clarity from the FDA around regulatory policies, medtech startups are now starting to rethink launching in the U.S.
A Rise in the Number of the Aged in Asia-Pacific Widens the Market for Home Care Devices, Finds Frost & SullivanMay 12, 2013 11:53 pm | by PR Newswire | News | Comments
KUALA LUMPUR, Malaysia, May 12, 2013 /PRNewswire/ -- Acknowledging the rapid aging of the population in Asia-Pacific, governments are encouraging patients to opt for home care by offering incentives, subsidies and tax cuts. While improving patients' quality of life, home care also...
Singapore-based Hoya Surgical Optics recalled 5 models of its intraocular lenses after receiving reports of higher-than expected rates of inflammation from doctors in several countries. Healthcare regulators in the U.K. and in Australia have both reported the recall, asking doctors to stop using the implants immediately.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, prices of interventional cardiology devices in Japan will see significant declines through 2021. The Japanese Ministry of Health, Labor and Welfare (MHLW) is implementing ...
A researcher at the Medical College of Wisconsin is charged with espionage after prosecutors say he stole details of a cancer-fighting compound that he wanted to share with China.
Analysts at PricewaterhouseCoopers say that life sciences companies that are ready to evolve along with China's shifting landscape will be in the best position to capitalize on what's projected to become a $1 trillion healthcare market within the decade.
In recent years, medical device companies in the U.S. and Europe have woken up to what pharmaceutical, industrial, and consumer goods companies have known for some time – China is a major growth opportunity. Even more recently, we've seen several well-known device companies step into the market more directly by buying domestic Chinese device companies.
Until now, physicians have largely been skeptical of the advantages of 3D technology. But this may be about to change: the findings of a new study show that even experienced surgeons stand to benefit from the third dimension.
Despite six decades of free medical care and widespread health campaigns, Britons are among the unhealthiest people in Western Europe, a new study says. International researchers analyzed the country's rates of sickness and death from 1990 to 2010 in comparison to those of 15 other Western...
- Page 1